Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
@article{Lecouvet2012CanWM, title={Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?}, author={F. Lecouvet and J. El Mouedden and L. Collette and E. Coche and Etienne Danse and F. Jamar and J. Machiels and B. V. Vande berg and P. Omoumi and B. Tombal}, journal={European urology}, year={2012}, volume={62 1}, pages={ 68-75 } }
BACKGROUND
Technetium Tc 99m bone scintigraphy (BS) and contrast-enhanced computed tomography (CT) or magnetic resonance imaging (MRI) of the pelvis and abdomen are universally recommended for detecting prostate cancer (PCa) metastases in cancer of all stages. [...] Key MethodDESIGN, SETTING, AND PARTICIPANTS
One hundred consecutive PCa patients at high risk for metastases prospectively underwent WBMRI, CT, and BS completed with targeted x-rays (BS/TXR) in case of equivocal BS.Expand Abstract
Figures, Tables, and Topics from this paper
Paper Mentions
Interventional Clinical Trial
Prostate cancer (PC) is the most common cancer among men and one quarter of diagnosed PC are
metastatic at the time of diagnosis. Accurate staging is paramount as the stage is the most… Expand
Conditions | High Risk Prostate Cancer |
---|---|
Intervention | Diagnostic Test |
Interventional Clinical Trial
This study will assess and compare the diagnostic performances and image quality of two WB 3D
T1-weighted MR imaging sequences for bone and node staging in patients with prostate cancer… Expand
Conditions | Metastasis, Prostate Adenocarcinoma |
---|---|
Intervention | Diagnostic Test |
229 Citations
Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial
- Medicine
- Acta oncologica
- 2016
- 113
- Highly Influenced
Whole-Body MRI with Diffusion-Weighted Imaging in Bone Metastases: A Narrative Review
- Medicine
- Diagnostics
- 2018
- 17
- PDF
Optimising TNM Staging of Patients with Prostate Cancer Using WB-MRI
- Medicine
- Journal of the Belgian Society of Radiology
- 2016
- 3
- PDF
Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.
- Medicine
- Academic radiology
- 2018
- 10
A Prospective Comparison of 18F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primar
- Medicine
- European urology oncology
- 2020
68Ga-PSMA-PET/CT in comparison with 18F-fluoride-PET/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer: a prospective diagnostic accuracy study
- Medicine
- European Radiology
- 2018
- 24
Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging
- Medicine
- European Radiology
- 2018
- 13
- PDF
Prospective Comparison of F-18 Choline PET/CT Scan Versus Axial MRI for Detecting Bone Metastasis in Biochemically Relapsed Prostate Cancer Patients
- Medicine
- Diagnostics
- 2017
- 5
- PDF
Prospective comparison of 68Ga-PSMA PET/CT, 18F-sodium fluoride PET/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancer
- Medicine
- European Journal of Nuclear Medicine and Molecular Imaging
- 2018
- 40
- Highly Influenced
References
SHOWING 1-10 OF 36 REFERENCES
Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2007
- 197
Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases.
- Medicine
- Radiology
- 2008
- 122
Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
- Medicine
- European urology
- 2011
- 142
Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
- Medicine
- Radiology
- 2008
- 160
Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET.
- Medicine
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine
- 1999
- 338
- PDF
Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.
- Medicine
- AJR. American journal of roentgenology
- 2001
- 409
Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa)
- Medicine
- European Radiology
- 2010
- 53
Whole‐body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer
- Medicine
- Journal of medical imaging and radiation oncology
- 2009
- 49
Whole body MRI for detecting metastatic bone tumor: comparison with bone scintigrams.
- Medicine
- Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine
- 2005
- 43
- PDF
The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
- Medicine
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine
- 2006
- 729
- PDF